Amed Co., Ltd.
Amed Co., Ltd. engages in the research and development, manufacture, and trading of medical equipment in Taiwan. It offers wound care dressing products under the HERADERM brand name; negative pressure wound therapy systems that provides 24-hour oxygen supply to wounds under the Genadyne brand name; and wound treatment systems under the Natrox brand name. The company also provides 7-day long-actin… Read more
Amed Co., Ltd. (7575) - Total Assets
Latest total assets as of June 2025: NT$1.16 Billion TWD
Based on the latest financial reports, Amed Co., Ltd. (7575) holds total assets worth NT$1.16 Billion TWD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Amed Co., Ltd. - Total Assets Trend (2019–2024)
This chart illustrates how Amed Co., Ltd.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Amed Co., Ltd. - Asset Composition Analysis
Current Asset Composition (December 2024)
Amed Co., Ltd.'s total assets of NT$1.16 Billion consist of 43.9% current assets and 56.2% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 7.2% |
| Accounts Receivable | NT$226.10 Million | 19.7% |
| Inventory | NT$166.08 Million | 14.5% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$72.25 Million | 6.3% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Amed Co., Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Amed Co., Ltd.'s current assets represent 43.9% of total assets in 2024, an increase from 36.9% in 2019.
- Cash Position: Cash and equivalents constituted 7.2% of total assets in 2024, down from 8.7% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, a decrease from 22.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 19.7% of total assets.
Amed Co., Ltd. Competitors by Total Assets
Key competitors of Amed Co., Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
Amed Co., Ltd. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Amed Co., Ltd. generates 0.71x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Amed Co., Ltd. generates $ 4.82 in net profit.
Amed Co., Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.21 | 1.46 | 1.37 |
| Quick Ratio | 0.74 | 1.11 | 0.93 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$92.34 Million | NT$ 163.06 Million | NT$ 108.86 Million |
Amed Co., Ltd. - Advanced Valuation Insights
This section examines the relationship between Amed Co., Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.10 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 29.4% |
| Total Assets | NT$1.15 Billion |
| Market Capitalization | $7.99K USD |
Valuation Analysis
Below Book Valuation: The market values Amed Co., Ltd.'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Amed Co., Ltd.'s assets grew by 29.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Amed Co., Ltd. (2019–2024)
The table below shows the annual total assets of Amed Co., Ltd. from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | NT$1.15 Billion | +29.36% |
| 2023-12-31 | NT$885.85 Million | +7.18% |
| 2022-12-31 | NT$826.52 Million | +11.64% |
| 2021-12-31 | NT$740.34 Million | +17.43% |
| 2020-12-31 | NT$630.45 Million | +8.95% |
| 2019-12-31 | NT$578.64 Million | -- |